![]() | Up a level |
Journal Article
Furman, Richard R., Hallek, Michael, Sharman, Jeffrey P., Hillmen, Peter, Zelenetz, Andrew D., Flinn, Ian W., Jurczak, Wojciech, Munugalavadla, Veerendra, Xiao, Yuanyuan, Zheng, Lianqing, Rao, Arati V., Dreiling, Lyndah K., Salles, Gilles A. and O'Brien, Susan M. (2016). Evaluation of Immune Mechanisms to Understand Idelalislib-Associated Diarrhea-Colitis. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020
Kreuzer, Karl-Anton, Furman, Richard, Stilgenbauer, Stephan, Dubowy, Ronald, Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweisz, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O'Brien, Susan, Pettitt, Andrew and Hallek, Michael (2017). Improved overall survival of relapsed chronic lymphocytic leukemia (CLL) patients exhibiting a complex karyotype and treated with idelalisib plus rituximab. Leuk. Lymphoma, 58. S. 167 - 169. ABINGDON: TAYLOR & FRANCIS LTD. ISSN 1029-2403
Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Cramer, Paula, Eichhorst, Barbara, Hillmen, Peter, O'Brien, Susan M., Pettitt, Andrew R. and Hallek, Michael (2020). The impact of complex karyotype on the overall survival of patients with relapsed chronic lymphocytic leukemia treated with idelalisib plus rituximab. Leukemia, 34 (1). S. 296 - 301. LONDON: NATURE PUBLISHING GROUP. ISSN 1476-5551
Kreuzer, Karl-Anton, Furman, Richard R., Stilgenbauer, Stephan, Dubowy, Ronald L., Kim, Yeonhee, Munugalavadla, Veerendra, Lilienweiss, Esther, Reinhardt, Hans Christian, Pettitt, Andrew R. and Hallek, Michael (2016). Outcome of Patients with Complex Karyotype in a Phase 3 Randomized Study of Idelalisib Plus Rituximab for Relapsed Chronic Lymphocytic Leukemia. Blood, 128 (22). WASHINGTON: AMER SOC HEMATOLOGY. ISSN 1528-0020